MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Abbott Laboratories

Closed

SectorHealthcare

123.73 2.37

Overview

Share price change

24h

Current

Min

123.53

Max

124.48

Key metrics

By Trading Economics

Income

-7.9B

1.3B

Sales

-616M

10B

P/E

Sector Avg

17.147

39.857

EPS

1.09

Dividend yield

1.74

Profit margin

12.792

Employees

114,000

EBITDA

-324M

2.7B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+17.79% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.74%

2.42%

Next Earnings

15 Oct 2025

Next Dividend date

15 Aug 2025

Next Ex Dividend date

14 Oct 2025

Market Stats

By TradingEconomics

Market Cap

1.9B

230B

Previous open

121.36

Previous close

123.73

News Sentiment

By Acuity

41%

59%

138 / 376 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Abbott Laboratories Chart

Past performance is not a reliable indicator of future results.

Related News

17 Jul 2025, 12:10 UTC

Earnings

Abbott Labs Pares Outlook, Logs 2Q Profit Gains

16 Apr 2025, 16:21 UTC

Earnings

Abbott Labs Bracing for Tariffs as Profits Rise -- Update

16 Apr 2025, 12:14 UTC

Earnings

Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices

17 Jul 2025, 13:14 UTC

Earnings

Abbott Labs Stock Falls After Earnings. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 Jul 2025, 12:16 UTC

Earnings

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 Jul 2025, 11:32 UTC

Earnings

Abbott Labs Sees 3Q Adj EPS $1.28-Adj EPS $1.32 >ABT

17 Jul 2025, 11:32 UTC

Earnings

Abbott Labs: See Momentum Carrying Into 2026 >ABT

17 Jul 2025, 11:31 UTC

Earnings

Abbott Labs Sees 2025 Organic Sales Up 7.5%-8%, Excluding Covid-19 Testing-Related Sales >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Rose 6.9% >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adjusted Operating Margin 22.9% >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adjusted Gross Margin 57% >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Growth Up 6.9% >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Sales $11.14B >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Net $1.78B >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adj EPS $1.26 >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $5.10-Adj EPS $5.20 >ABT

17 Jul 2025, 11:30 UTC

Earnings

Abbott Labs 2Q EPS $1.01 >ABT

17 Jul 2025, 09:08 UTC

Hot Stocks

Stocks to Watch Thursday: TSMC, United Airlines, Sarepta -- WSJ

1 Jul 2025, 18:41 UTC

Acquisitions, Mergers, Takeovers

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

16 Apr 2025, 15:09 UTC

Market Talk

Abbott Says Tariffs Killed Chances of an Outlook Raise -- Market Talk

16 Apr 2025, 14:17 UTC

Earnings

Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations -- Barrons.com

16 Apr 2025, 11:34 UTC

Earnings

Abbott Labs 1Q Gross Margin of 52.8 % of Sales; Adj Gross Margin of 57.1 % >ABT

16 Apr 2025, 11:33 UTC

Earnings

Abbott Labs Projects FY25 Adj Operating Margin to Be 23.5% to 24.0% of Sales >ABT

16 Apr 2025, 11:32 UTC

Earnings

Abbott Labs Backs FY25 Adj EPS $5.05-Adj EPS $5.25 >ABT

16 Apr 2025, 11:32 UTC

Earnings

Abbott Labs Sees 2Q Adj EPS $1.23-Adj EPS $1.27 >ABT

16 Apr 2025, 11:31 UTC

Earnings

Abbott Labs Projects FY25 Organic Sales Growth of 7.5% to 8.5% >ABT

16 Apr 2025, 11:30 UTC

Earnings

Abbott Reaffirms Full-Yr Guidance

16 Apr 2025, 11:30 UTC

Earnings

Abbott Labs 1Q Organic Sales Growth Up 6.9% >ABT

16 Apr 2025, 11:30 UTC

Earnings

Abbott Labs 1Q Sales $10.36B >ABT

16 Apr 2025, 11:30 UTC

Earnings

Abbott Labs 1Q Net $1.33B >ABT

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

17.79% upside

12 Months Forecast

Average 145.67 USD  17.79%

High 159 USD

Low 135 USD

Based on 19 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

16

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

132.82 / 134.43Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

138 / 376 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.